Introduction
A thrombus clot of blood and product of the blood coagulation step in hemostasis. The components that lead to a thrombus are aggregated platelets that form a plug, and a net work of cross-linked fibrin protein. A thrombus is a response to injury to stop bleeding, but can be harmful in thrombosis, when blocks blood flow through healthy blood vessels (Saladin and Kenneth, 2012) . The factor V gene is located on chromosome (1), the gene extends 70 kb, consists of 25 exons, and the translation protein has a molecular mass of approximately 330 kDa .Patients with multiple genetic defects in the hemostaticthrombotic system may have an increased risk of thrombosis compared with patients with single defects. Several studies demonstrated a frequent association of the prothrombin G20210A mutation and the factor V Leiden mutation in patients with thrombophilia (Neil et al., 2000) . The high allele frequency of the mutated factor V gene, homozygous carriers will not be extremely rare as in other types of hereditary thrombophilia. It has been estimated the risk of thrombosis and the clinical features of patients who were homozygous for factor V Leiden (Rosendaal et al., 1995) .
Purpose of the study presented in this article is to identify type and location of the genetic change that led to thrombosis in Iraqi patients and Leiden mutation in F5 gene.
Materials and Methods
Study and control population: The study included one hundred blood samples from patients suffering thrombosis during the period November 2015 to January 2016, collected from AL Kadhimiya Teaching Hospital and AL Yarmouk Teaching Hospital (Baghdad / Iraq). The average ages of patients and control group were 30-80 years.
Troponin test (TNI) was performed according to (Jahangir, 2010 
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The products from PCR amplification were sent for sequencing by Macrogen Company (Korea) and data obtained were analyzed using (Mega -7) software and compared to their similar at the National Center for Biotechnology Information (NCBI).
Statistical Analysis:
The Statistical Analysis System-SAS (2012) program was used to determine the association of thrombosis to age group and gender using chi square test.
Result and discussion
In this study, one hundred samples have been collected from patient diagnosed with thrombosis and used to determine the relation of age and gender in the manifestation of thrombosis using chi-square test. Results are shown in Table ( 2 and 3). Ages between 50-60 years showed higher thrombosis percentage especially in male over female in Iraqi patients. In arterial thrombosis at young age, traditional risk factors such as gender , smoking, diabetes mellitus, obesity and hypercholesterolemia might interfere the cardiovascular risk that may cause high blood pressure, arterial blood vessel block which eventually lead to thrombosis.
Molecular Detection of Thrombosis by PCR Technique
Factor V gene The coagulation factors represent a group of similar proteins that construct the protective coagulation system, multiple chemical reactions that form blood clots. When injury, clots seal off blood vessels to prevent bleeding and start blood vessel repair. The F5 gene controls a protein called coagulation factor V (Asselta et al., 2006) . The protein is inactive in the blood stream till the coagulation system is active by an injury to the blood vessels. When coagulation factor V is active, it combines with factor X, and the active forms of these two coagulation factors make a complex that affect coagulation protein called prothrombin to its active form, thrombin. Thrombin affects the fibrinogen to become fibrin, which is the substance that forms the clot (Asselta and Peyvandi, 2009 ). 
Molecular Analysis of F5 Gene
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Discussion
Thrombosis is a dangerous disease that may cause lethal clinical cases if not diagnosed earlier.
About 50000 deaths per year may result from this disease (Slusher, 2010) . Factor V Leiden thrombophilia is diagnosed by a poor anticoagulant response to activated protein C (APC) and and high risk for venous thromboembolism (VTE). Deep vein thrombosis (DVT) is the most common VTE, with the legs being the most common site. The molecular basis of Factor V Leiden is a missense mutation in the factor V (FV) gene at G1691A, resulting in R506 being changed to glutamine (R506Q) (Van Cott et al., 2015) . Gender specific mutation of Factor V Leiden may be associated with evolutionary state. Women who carry this mutation may lose less blood during menstruation (Dunné et al., 2006) .
However, we found an increased risk of Factor V Leiden with age. Most of patients showed the symptoms of thrombosis are elderly ages. Most of them suffered from high blood pressure, high blood viscosity, high LDL, and less movement due to age which consequently drove the DVT to be diagnosed in most of them.
Mutation led to Factor V Leiden in Iraqi patients did not differ from that found around the world, but interestingly Hong Kong V mutation was detected in some patients subjected to this study.
Moreover, analysis of open reading frame in the sequence studied showed a significant difference, since the normal sequence appeared with one ORF, where as the affected sequence appeared with 2 ORFs suggesting complete disruption response to activated C protein. Each ORF is directed oppositely from the other one. 
